- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc4d38e4-7e63-4929-ae49-9a2d727e0280&Preview=1 - Date
3/26/2010 - Company Name
Adaptive TCR - Mailing Address
307 Westlake Ave N Seattle, WA 98109 - Company Description
Adaptive TCR Corporation’s platform technology breaks open the field of genomics immunology. T-cell receptor profiling using Adaptive’s proprietary technology and software allows scientists to study the adaptive immune system to an unprecedented depth via high-throughput T-Cell Receptor (TCR) sequencing. Adaptive provides T-cell receptor profiling as a service to the research community. - Website
http://www.adaptivetcr.com - Transaction Type
Venture Equity - Transaction Amount
$4,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Undisclosed